Showing 281 - 300 results of 2,687 for search '"chemotherapy"', query time: 0.06s Refine Results
  1. 281
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286
  7. 287

    Radiotherapy Combined with Immunotherapy and Chemotherapy Improves Prognosis and Demonstrates Synergistic Effects in Extensive-stage Small Cell Lung Cancer by Huaijun JI, Meiling SUN, Jingyi LI, Ge YU, Yongbing CHEN

    Published 2024-11-01
    “…This study aims to evaluate the efficacy and synergistic effects of radiotherapy (RT) combined with immunotherapy (IT) and chemotherapy (CT) in patients with ES-SCLC. Methods A retrospective analysis was performed on 145 ES-SCLC patients treated with first-line CT. …”
    Get full text
    Article
  8. 288
  9. 289
  10. 290
  11. 291

    Changes in Hepatic Blood Flow and Liver Function during Closed Abdominal Hyperthermic Intraperitoneal Chemotherapy following Cytoreduction Surgery by Stéphanie Dupont, Eduardo R. C. Schiffer, Marion J. White, John R. A. Diaper, Marc-Joseph Licker, Philippe C. Masouyé

    Published 2018-01-01
    “…The increase in intra-abdominal pressure (IAP) during closed abdominal hyperthermic intraperitoneal chemotherapy (HIPEC) leads to major haemodynamic changes and potential organ dysfunction. …”
    Get full text
    Article
  12. 292
  13. 293

    Life-threatening Pneumocystis jiroveci Pneumonia with Cytomegalovirus Coinfection in a Follicular Lymphoma Patient During Rituximab-based Chemotherapy by Mu-Chun Yang, Sheng-Kang Chiu, Jong-Kai Hsiao, Woei-Yau Kao

    Published 2024-01-01
    “…In the era of target therapy, we face the challenge of the risk of opportunistic infection in patients with B-cell lymphoma who receiving rituximab-based chemotherapy. Opportunistic infections such as Pneumocystis jiroveci pneumonia (PJP) and Cytomegalovirus (CMV) pneumonia are life-threatening diseases. …”
    Get full text
    Article
  14. 294
  15. 295
  16. 296
  17. 297
  18. 298
  19. 299

    Renal impairment as a risk factor for chemotherapy induced neutropenia in the treatment of trifluridine/thymidine phosphorylase inhibitor plus bevacizumab by Masatsune Shibutani, Hideki Tanda, Hiroaki Kasashima, Tatsunari Fukuoka, Shinichiro Kashiwagi, Kiyoshi Maeda

    Published 2025-01-01
    “…This study aimed to investigate the relationship between renal impairment and the incidence of chemotherapy-induced neutropenia during FTD/TPI + Bmab therapy using real-world data. …”
    Get full text
    Article
  20. 300